Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Melbourne man tests positive to HIV while taking preventative drug

A man has tested positive to HIV at a Melbourne clinic while participating in a trial of PrEP, an antiretroviral drug credited with preventing the spread of the disease. It's understood just over a week ago, he tested positive to HIV at a Melbourne clinic. On Monday, a spokesman at The Alfred confirmed researchers were "reviewing the clinical details of a man who has tested positive to HIV while being a registered participant of the Victorian PrEPX study."

Published
22 May 2017
From
The Age (Melbourne)
PrEP in the Transgender Population: New Study to Examine Effects

Transgender women are a fast-growing and disenfranchised population of HIV-positive people in the United States, but few opportunities are available for transgender individuals to be involved in HIV research. Including the transgender community in HIV studies is necessary to design preventive and curative approaches that can be applied across the entire spectrum of genders.

Published
22 May 2017
From
Infectious Disease Advisor
Many physicians are wary of providing HIV PrEP for young people

Only about a third of family practice and paediatric providers said they would be likely to prescribe HIV pre-exposure prophylaxis (PrEP) to adolescent patients, underlining the need to

Published
22 May 2017
By
Liz Highleyman
United States: A GOP Health Care Plan May Ruin Our Best Chance At Ending HIV And AIDS

Though it’s unclear how (or if) the ACA will be repealed, the plan passed by the House this month would certainly lead to fewer insured Americans and, by extension, fewer patients able to afford PrEP.

Published
17 May 2017
From
Huffington Post
Teen PrEP program ramps up in San Francisco

Three youth clinics of San Francisco Department of Public Health (SFDPH)—Cole Street Youth Clinic, Dimensions Queer Youth Clinic, and the Michael Baxter Larkin Street Youth Clinic—are providing comprehensive PrEP services for young people ages 12 to 24.

Published
11 May 2017
From
BETA blog
Lib Dems say HIV prevention drug should be available on NHS

Lib Dem health spokesman Norman Lamb said: "PrEP is a vital weapon in the fight against HIV, and it's high time that it was made routinely available to those who are at risk of infection."

Published
10 May 2017
From
Evening Standard
Gilead slowly rolls out ads for Truvada for PrEP — 4 years after approval

Gradually ramping up promotion of its HIV-prevention pill, Gilead Sciences has turned to humor, dating apps, and social-media sites like Tumblr and Snapchat to raise awareness about HIV prevention.

Published
08 May 2017
From
Medical Marketing & Media
Kenya launches self-test kits and PrEP

The Government of Kenya has reinforced its commitment to end AIDS by 2030 by launching two innovative technologies: self-testing for HIV and PrEP.

Published
05 May 2017
From
UNAIDS
HIV, Vaginal Sex and PrEP Initiation: What Should You Tell Your Patients or Clients?

This year, pre-exposure prophylaxis (PrEP) advocates noted a stunning disconnect between key organizations that issue guidelines on the use of tenofovir/emtricitabine (TDF/FTC, Truvada) for HIV prevention: The United States Centers for Disease Control and Prevention (CDC) continues to say that people need 20 days of daily TDF/FTC before they can consider themselves protected from vaginal HIV exposure -- but the World Health Organization (WHO) has stated that just seven days of the drug is enough.

Published
03 May 2017
From
The Body Pro
IPM Advances Three-month HIV Prevention and Contraception Ring to Clinical Trial

The three-month vaginal ring is designed to slowly — and simultaneously — release the antiretroviral drug dapivirine to prevent HIV and the contraceptive hormone levonorgestrel. The primary goal of the study, known as MTN-030/IPM 041, is to assess the ring’s safety and pharmacokinetics (how the body processes the two drugs). Results of the trial, including the product’s acceptability to women and their willingness to use it in the future, will inform next steps for the ring’s formulation and future trial designs.

Published
03 May 2017
From
International Partnership for Microbicides
← First12345...111Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.